Recently, serum and urine neutrophil gelatinase-associated lipocalin (NGAL) levels were used as a biomarker to early diagnosis of AKI in both SA-AKI and non-SA-AKI patients [11–13]. Here, LCN2 is linked to acute kidney injury.